Arkansas Legal Resource Navigator

42 U.S.C. § 3512 — Office to assist small manufacturers of medical devices; establishment

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 3512 — Office to assist small manufacturers of medical devices; establishment

The Secretary of Health and Human Services shall establish within the Department of Health and Human Services an identifiable office to provide technical and other nonfinancial assistance to small manufacturers of medical devices to assist them in complying with the requirements of the Federal Food, Drug, and Cosmetic Act [[21 U.S.C. 301](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section301&num=0&edition=prelim) et seq.], as amended by this Act.

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 3512

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 07c1228cd82eb9dce8d218c45c8fe0b66524f1afd3779839f050bee387284461. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_ba460ff5ccde6951dc03166e
Source file: Laws/federal/codes/united-states-code/title-42/section-3512-office-to-assist-small-manufacturers-of-medical-devices-establishment--ab1605d472.md
Pages: Not recorded – Not recorded
Passage SHA-256: 99f06bf5176864d0e4f863703a1a8197a05db2dec7b5e721b82bdb7b8fce9278

Source location: Title 42, Chapter 43, § 3512; chapter-043-department-of-health-and-human-services.md

Stored source content

The Secretary of Health and Human Services shall establish within the Department of Health and Human Services an identifiable office to provide technical and other nonfinancial assistance to small manufacturers of medical devices to assist them in complying with the requirements of the Federal Food, Drug, and Cosmetic Act [[21 U.S.C. 301](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section301&num=0&edition=prelim) et seq.], as amended by this Act.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

This chapter may be cited as the Federal Food, Drug, and Cosmetic Act.

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 301

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

15 U.S.C. § 55 — Additional definitions

For the purposes of sections 52 to 54 of this title— **(a) False advertisement** (1) The term “false advertisement” means an advertisement, other than labeling, which is misleading in a material respect; and in determining whether any advertisement is misleading, there shall be taken into account (among other things) not only representations made or suggested by statement, word, design, device, sound, or any combination thereof, but also the extent to which the advertisement fails to reveal facts material in the light of such representations or material with respect to consequences which may result from the use of the commodity to which the advertisement relates under the conditions prescribed in said advertisement, or under such conditions as are customary or usual. No advertisement of a drug shall be deemed to be false if it is disseminated only to members of the medical profession, contains no false representation of a material fact, and includes, or is accompanied in each instance by truthful disclosure of, the formula showing quantitatively each ingredient of such drug. (2) In the case of oleomargarine or margarine an advertisement shall be deemed misleading in a material respect if in such advertisement representations are made or suggested by statement, word, grade designation, design, device, symbol, sound, or any combination thereof, that such oleomargarine or margarine is a dairy product, except that nothing contained herein shall prevent a truthful, accurate, and full statement in any such advertisement of all the ingredients contained in such oleomargarine or margarine. **(b) Food** The term “food” means (1) articles used for food or drink for man or other animals, (2) chewing gum, and (3) articles used for components of any such article. **(c) Drug** T

Source: Supplied U.S. Code snapshot — release unconfirmed · 15 U.S.C. § 55

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 360c — Classification of devices intended for human use

**(a) Classes of devices** (1) There are established the following classes of devices intended for human use: (A) *Class I, General Controls.—* (i) A device for which the controls authorized by or under section 351, 352, 360, 360f, 360h, 360i, or 360j of this title or any combination of such sections are sufficient to provide reasonable assurance of the safety and effectiveness of the device. (ii) A device for which insufficient information exists to determine that the controls referred to in clause (i) are sufficient to provide reasonable assurance of the safety and effectiveness of the device or to establish special controls to provide such assurance, but because it— (I) is not purported or represented to be for a use in supporting or sustaining human life or for a use which is of substantial importance in preventing impairment of human health, and (II) does not present a potential unreasonable risk of illness or injury, is to be regulated by the controls referred to in clause (i). (B) *Class II, Special Controls.—* — A device which cannot be classified as a class I device because the general controls by themselves are insufficient to provide reasonable assurance of the safety and effectiveness of the device, and for which there is sufficient information to establish special controls to provide such assurance, including the promulgation of performance standards, postmarket surveillance, patient registries, development and dissemination of guidelines (including guidelines for the submission of clinical data in premarket notification submissions in accordance with [section 360(k) of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section360/k&num=0&edition=prelim)), recommendations, and other appropri

Source: Supplied U.S. Code snapshot — release unconfirmed · 21 U.S.C. § 360c

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

21 U.S.C. § 301 — Short title

Page 30 TITLE 21—FOOD AND DRUGS § 301 Sec. 398. Notices to States regarding imported food. 399. Grants to enhance food safety. 399a. Office of the Chief Scientist. 399b. Office of Women’s Health. 399c. Improving the training of State, local, terri- torial, and tribal food safety officials. 399d. Employee protections. 399e. Nanotechnology. 399f. Ensuring adequate information regarding pharmaceuticals for all populations, par- ticularly underrepresented subpopulations, including racial subgroups. 399g. Food and Drug Administration Intercenter Institutes. 399h. National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufac- turing. 399i. Food and Drug Administration Working Cap- ital Fund. SUBCHAPTER I—SHORT TITLE § 301. Short title This chapter may be cited as the Federal Food, Drug, and Cosmetic Act. (June 25, 1938, ch. 675, § 1, 52 Stat. 1040.) Statutory Notes and Related Subsidiaries EFFECTIVE DATE; POSTPONEMENT IN CERTAIN CASES Act June 23, 1939, ch. 242, §§ 1, 2, 53 Stat. 853, 854, pro- vided that: ‘‘[SEC. 1] (a) The effective date of the following provi- sions of the Federal Food, Drug, and Cosmetic Act is hereby postponed until January 1, 1940: Sections 402(c) [342(c) of this title]; 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k) of this title]; 501(a), (4) [351(a)(4) of this title]; 502(b), (d), (e), (f), (g), and (h) [352(b), (d) to (h) of this title]; 601(e) [361(e) of this title]; and 602(b) [362(b) of this title]. ‘‘(b) The Secretary of Agriculture shall promulgate regulations further postponing to July 1, 1940[,] the ef- fective date of the provisions of sections 403(e)(1) [343(e)(1) of this title]; 403(g), (h), (i), (j), and (k) [343(g) to (k)]; 502(b), (d), (

Source: Supplied 2024 U.S. Code historical extraction · 21 U.S.C. § 301

Stored review status: historical_2024_not_currentness_verified. The source passage cites 21 U.S.C. § 301. This identifies an authority to review, not proof of applicability.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 3512 — Office to assist small manufacturers of

Page 5911 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 3513 Sept. 19, 1964, Pub. L. 88–605, title II, § 202, 78 Stat. 979. Oct. 11, 1963, Pub. L. 88–136, title II, § 202, 77 Stat. 244. Aug. 14, 1962, Pub. L. 87–582, title II, § 202, 76 Stat. 379. Sept. 22, 1961, Pub. L. 87–290, title II, § 203, 75 Stat. 608. Sept. 2, 1960, Pub. L. 86–703, title II, § 203, 74 Stat. 773. Aug. 14, 1959, Pub. L. 86–158, title II, § 205, 73 Stat. 355. Aug. 1, 1958, Pub. L. 85–580, title II, § 206, 72 Stat. 473. June 29, 1957, Pub. L. 85–67, title II, § 207, 71 Stat. 224. June 29, 1956, ch. 477, title II, § 207, 70 Stat. 436. Aug. 1, 1955, ch. 437, title II, § 206, 69 Stat. 410. July 2, 1954, ch. 457, title II, § 206, 68 Stat. 445. July 31, 1953, ch. 296, title II, § 206, 67 Stat. 257. Section was formerly classified to section 623a of former Title 5, Executive Departments and Govern- ment Officers and Employees, prior to the general revi- sion and enactment of Title 5, Government Organiza- tion and Employees, by Pub. L. 89–554, § 1, Sept. 1, 1966, 80 Stat. 378. § 3509. Repealed. Pub. L. 105–362, title VI, § 601(a)(2)(C), Nov. 10, 1998, 112 Stat. 3285 Section, Pub. L. 91–513, title IV, § 1200, Oct. 27, 1970, 84 Stat. 1296; Pub. L. 96–88, title V, § 509(b), Oct. 17, 1979, 93 Stat. 695; Pub. L. 103–437, § 15(m), Nov. 2, 1994, 108 Stat. 4593, related to annual report by Secretary of Health and Human Services on statutory advisory councils. §§ 3510, 3511. Transferred Editorial Notes CODIFICATION Section 3510, Pub. L. 91–667, title II, Jan. 11, 1971, 84 Stat. 2015, which related to the Working Capital Fund, was transferred to section 3513a of this title. Section 3511, Pub. L. 93–282, title II, § 201, May 14, 1974, 88 Stat. 134; Pub. L. 94–371, § 8, July 26, 1976, 90 Stat. 1

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 3512

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.